TAVI innovations: late-breaking trials from PCR London Valves 2024

Session comprising selected PCR London Valves 2024 Late-Breaking Trials submissions

Facilitators: E. Barbato, A. Damonte
SHOW MORE

Summary

What does the future hold for TAVI procedures? Don’t miss the latest innovations—watch this video now! It explores the Late-Breaking Trials from PCR London Valves 2024, featuring groundbreaking studies that could transform the way we approach TAVI in clinical practice.

You’ll dive into the CANNULATE TAVR EXTENDED Study, which examines the impact of commissural and coronary alignment on coronary cannulation after TAVI with Evolut FX, discover the long-term results from the International Chimney Stent Registry, learn how the DurAVR TAVI biomimetic design is contributing to significant left ventricular mass regression, and much more!

Presentations available when logged in:

  • Impact of commissural and coronary alignment on coronary cannulation after TAVI with Evolut FX
  • Long-term results from International Chimney Stent Registry
  • DurAVR TAVI: biomimetic design restores flow and leads to significant left ventricular mass regression - MRI study
  • US pivotal study of the Vivasure PerQseal system for large hole closure: PATCH
  • Live case interventional cardiology procedures are safe: outcomes from a multicentre registry